Sucralfate Oral Suspension

广东逸舒制药股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8H1OqvsqfpA
Approval Number: 国药准字H20227074
Generic Name: 硫糖铝口服混悬液
Generic Name En: Sucralfate Oral Suspension
Trade Name: 迪先
Drug Type: 化学药品
Dosage Form: 口服混悬剂
Strength: 5ml：1g
Reg Date: 2022-06-02
Company Name: 广东逸舒制药股份有限公司
Company Address: 广东省肇庆高新区凤岗西街6号
Production Company Name: 广东华南药业集团有限公司
Production Company Address: 东莞市石龙镇西湖工业区信息产业园
Company Detail Path: /organization/yan-dong-yi-shu-zhi-yao-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/yan-dong-hua-nan-yao-ye-ji-tuan-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 2, 2022

Approval ID

8H1OqvsqfpA

Type

化学药品